FLUTICASONE PROPIONATE | A077570 | HIKMA PHARMACEUTICALS USA INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultant Services, Inc. FDA-2016-P-1725 · 5 docket documents Lachman Consultant Services, Inc. filed this petition on behalf of a client requesting that the FDA determine whether GSK's Flonase (fluticasone propionate) Nasal Spray, 0.05 mg (Rx), approved under NDA 020121, has been voluntarily withdrawn for safety or effectiveness reasons, and if not, to design | 505(q) | 2016-06-23 | Granted | Lachman Consultant Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.